AJ - BPPOPIOIDS Research Letter
AJ - BPPOPIOIDS Research Letter
AJ - BPPOPIOIDS Research Letter
Encounter of Low Back Pain in the Primary Care Setting: Analysis of a Private Payer
Micheal Raad*, MD, Jina Pakpoor*, MD, Andrew Harris, Varun Puvaresanajah, MD, Joseph
This study examines opioid prescribing practices among primary care physicians after initial
encounters for low back pain in privately insured patients. The Truven Health
MarketScan® Commercial Claims and Encounters Database, which contains health information
on private-payer insurance beneficiaries from approximately 350 payers was utilized for this
study1. International Classification of Diseases 9th and 10th (ICD-9 724.2 or ICD-10 M54.4)
edition codes were used to identify patients in the outpatient setting presenting for an initial
encounter for isolated low back pain after a 1 year look back period. Patients with other
diagnoses indicating any spinal pathology were excluded. Similarly excluded were patients who
had filled opioid prescriptions in the 90 days prior to their encounter, required opioid forms
indicating more chronic use or those who were seen by a specialist. The primary outcome was
whether an opioid prescription was filled in the 30 days after the visit date. The proportion of
patients with a daily morphine milligram equivalence (MME/day) known to be associated with a
higher risk of over dose was also analyzed2. All proportions were imputed with Truven Health
MarketScan® trends and sampling weights. The Cochran-Armitage trends test was used to
analyze trends over time. Variation between states was analyzed using chi-square test and
caterpillar plots showing 95% logit confidence intervals (CI). Institutional review board approval
Results
418,565 patients between January 1 2011 and November 30, 2016 were included in this study.
Age was 44.7 [95% CI: 44.6 – 44.7] and 52.7% [52.6 – 52.9] were women. 25.7% [25.6 – 25.9]
of patients had a filled opioid prescription. Nationally, the proportion of patients with filled
opioid prescriptions declined significantly between 2011 and 2016 (p< 0.01: 28.5% in 2011,
27.6% in 2012, 26.3% in 2013, 25.5% in 2014, 23.5% in 2015, 20.4% in 2016). This decline was
evident across the Northeast, Midwest, South and West. Figure 1. Of those with a filled opioid
prescription, the proportion with > 20MME/day did not significantly change over time (p=0.16).
This varied significantly between the four regions with a decline in the Northeast and South
(p<0.01), no significant change in the Midwest (p=.09) and a rise in the West (p<0.01). Figure 1.
The proportion of patients with a filled opioid prescription varied significantly between the
various states (p<0.01), ranging from 12.9% in Hawaii to 33.6% in Arkansas. Figure 2.
Figure 1. Regional Scatter Plots of the Annual Proportions of Patients with Any filled Opioid
Prescription as well as the Proportion of those with a Filled Prescription Receiving More than 20
A. Northeast
B. Midwest
C. South
D. West
Figure 2. A Caterpillar Plot of the Proportion of Patients with a Filled Opioid Prescription